SirPAD Subgroup Study at VIVA 2026 Focuses on Femoropopliteal PAD in Patients With Claudication

ConferenceSirPADNeutral

AI Analysis

Summary

SirPAD randomized trial results focusing on femoropopliteal PAD patients with intermittent claudication will be presented at VIVA 2026 conference in October. The trial randomized 1,252 patients.

Clinical Trial Data

Patients

1,252

Importance:4/10

Sentiment:

0.00

peripheral_artery_diseaseclinical_trialconference_presentationrandomized_trialclaudication

Read the original article

Published by PR Newswire Clinical Trials on September 21, 2026 8:19 AM

Read Original